Stock TBPH THERAVANCE BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Theravance Biopharma, Inc.

Equities

TBPH

KYG8807B1068

Market Closed - Nasdaq
Other stock markets
 21:00:00 13/05/2024 BST 		5-day change 1st Jan Change
9.58 USD +2.13% Intraday chart for Theravance Biopharma, Inc. -0.21% -14.77%
05-13 Theravance Narrows Q1 Loss as Revenue Rises; Shares Rise After-hours MT
05-13 Transcript : Theravance Biopharma, Inc., Q1 2024 Earnings Call, May 13, 2024
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
THERAVANCE BIOPHARMA, INC. Stock Theravance Biopharma, Inc.
 465M - - -
ELI LILLY AND COMPANY Stock Eli Lilly and Company
 682B
NOVO NORDISK A/S Stock Novo Nordisk A/S
 586B
JOHNSON & JOHNSON Stock Johnson & Johnson
 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
 327B
ABBVIE INC. Stock AbbVie Inc.
 285B
  1. Stock Market
  2. Equities
  3. TBPH Stock
  4. Charts Theravance Biopharma, Inc.
  5. Sector Chart